Mediclinic International Plc

Public consensus   -   Last updated 11/01/22

Contributors

  • 12 FY23 based on
  • 12 FY24 based on
  • 11 FY25 based on
  • 9 FY26 based on
Reporting currency: GBP
Reporting unit: Absolute
FY23
CONSENSUS
11/01/22
FY24
CONSENSUS
11/01/22
FY25
CONSENSUS
11/01/22
FY26
CONSENSUS
11/01/22
Hirslanden (CHF'm) - Adjusted
Revenue
1,910
1,948
1,980
2,039
EBITDA
307
317
327
336
EBITDA margin (%)
16.1
16.3
16.5
16.5
Average FX rate GBP/CHF
1.25
1.25
1.25
1.24
Southern Africa (ZAR'm) - Adjusted
Revenue
19,296
20,261
20,971
22,007
EBITDA
3,862
4,155
4,309
4,525
EBITDA margin (%)
20.0
20.5
20.5
20.6
Average FX rate GBP/ZAR
20.68
20.89
21.13
21.46
Middle East (AED'm) - Adjusted
Revenue
4,331
4,549
4,720
4,924
EBITDA
679
741
794
837
EBITDA margin (%)
15.7
16.3
16.8
17.0
Average FX rate GBP/AED
5.01
5.00
5.03
4.99
Adjusted Group (GBP'm)
Revenue
3,335
3,448
3,526
3,657
EBITDA
566
599
622
647
EBITDA margin (%)
17.0
17.4
17.6
17.7
D&A
(230)
(235)
(236)
(241)
Operating profit
336
365
386
406
Net finance cost
(68)
(67)
(63)
(62)
Share of profit of equity accounted investment
8
10
11
13
Earnings (equity holders)
199
226
247
264
Earnings per share (pence)
27.1
30.6
33.5
35.8
Dividend per share (pence)
7.2
8.4
9.2
10.0
Net Debt
1,965
1,810
1,629
1,471
Net cash generated from operating activities
426
464
485
512
Total Group Capex
208
210
217
227

Disclaimer

Mediclinic International plc (“Mediclinic”) does not endorse or adopt any of the consensus estimates expressed in this report. The report represents the views of analysts from which the consensus estimates are derived. Mediclinic will not provide any commentary on the consensus or answer questions on it. The circulation of the consensus by Mediclinic is not mandatory and Mediclinic may amend its practice on this at any time.